GUJARAT THEMIS BIOSYN LIMITED : INTER-SE TRANSFER OF EQUITY SHARES WORTH UP TO RS 20 CR

• Sachin D. Patel to acquire up to 5,25,000 equity shares from Pharmaceutical Business Group (India) Limited. • The transaction is an inter-se transfer between promoters and the promoter group. • Proposed acquisition price is Rs. 395.75 per equity share, not exceeding Rs. 20 Cr. • VWAP for the 60 trading days preceding the notice is Rs. 376.60 per equity share. • Post-transaction, acquirer's shareholding will be 2.77% (24,97,200 shares) and seller's will be 46.54% (5,07,15,000 shares). Impact: Neutral (Standard promoter group shareholding adjustment as per SEBI regulations.)

Gujarat Themis Biosyn Ltd

Open attachment

← Back to feed